vs
Side-by-side financial comparison of GERON CORP (GERN) and NexPoint Residential Trust, Inc. (NXRT). Click either name above to swap in a different company.
NexPoint Residential Trust, Inc. is the larger business by last-quarter revenue ($62.1M vs $47.2M, roughly 1.3× GERON CORP). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -2.7%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs -4.1%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
NexPoint Residential Trust, Inc. is a publicly traded real estate investment trust focused on acquiring, renovating, and operating multifamily residential properties primarily across high-growth Sun Belt markets in the United States. Its portfolio consists mainly of affordable and mid-tier apartment communities, targeting steady rental income growth and long-term asset value appreciation for investors.
GERN vs NXRT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $62.1M |
| Net Profit | $-18.4M | — |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 8.4% |
| Net Margin | -39.0% | — |
| Revenue YoY | 67.1% | -2.7% |
| Net Profit YoY | 30.3% | — |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.1M | ||
| Q3 25 | $47.2M | $62.8M | ||
| Q2 25 | $49.0M | $63.1M | ||
| Q1 25 | $39.6M | $63.2M | ||
| Q4 24 | — | $63.8M | ||
| Q3 24 | $28.3M | $64.1M | ||
| Q2 24 | $882.0K | $64.2M | ||
| Q1 24 | $304.0K | $67.6M |
| Q4 25 | — | — | ||
| Q3 25 | $-18.4M | $-7.8M | ||
| Q2 25 | $-16.4M | $-7.0M | ||
| Q1 25 | $-19.8M | $-6.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.4M | $-8.9M | ||
| Q2 24 | $-67.4M | $10.6M | ||
| Q1 24 | $-55.4M | $26.3M |
| Q4 25 | — | 8.4% | ||
| Q3 25 | -29.4% | 11.8% | ||
| Q2 25 | -25.4% | 12.5% | ||
| Q1 25 | -42.2% | 11.7% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | -99.8% | 8.7% | ||
| Q2 24 | -7860.9% | 39.7% | ||
| Q1 24 | -18465.1% | 60.7% |
| Q4 25 | — | — | ||
| Q3 25 | -39.0% | -12.4% | ||
| Q2 25 | -33.4% | -11.1% | ||
| Q1 25 | -50.1% | -10.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -93.5% | -13.8% | ||
| Q2 24 | -7639.8% | 16.5% | ||
| Q1 24 | -18220.4% | 38.9% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.03 | $-0.31 | ||
| Q2 25 | $-0.02 | $-0.28 | ||
| Q1 25 | $-0.03 | $-0.27 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.04 | $-0.35 | ||
| Q2 24 | $-0.10 | $0.40 | ||
| Q1 24 | $-0.09 | $1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $13.7M |
| Total DebtLower is stronger | — | $1.6B |
| Stockholders' EquityBook value | $248.7M | $295.5M |
| Total Assets | $567.4M | $1.9B |
| Debt / EquityLower = less leverage | — | 5.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.7M | ||
| Q3 25 | $78.1M | $10.8M | ||
| Q2 25 | $77.7M | $13.6M | ||
| Q1 25 | $83.7M | $23.7M | ||
| Q4 24 | — | $23.1M | ||
| Q3 24 | $60.3M | $17.4M | ||
| Q2 24 | $116.9M | $21.3M | ||
| Q1 24 | $189.8M | $37.2M |
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | $295.5M | ||
| Q3 25 | $248.7M | $322.9M | ||
| Q2 25 | $259.5M | $347.9M | ||
| Q1 25 | $268.2M | $379.9M | ||
| Q4 24 | — | $410.4M | ||
| Q3 24 | $292.3M | $447.1M | ||
| Q2 24 | $306.7M | $491.1M | ||
| Q1 24 | $344.9M | $512.8M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | $567.4M | $1.8B | ||
| Q2 25 | $555.2M | $1.9B | ||
| Q1 25 | $562.5M | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | $444.9M | $2.0B | ||
| Q2 24 | $449.4M | $2.0B | ||
| Q1 24 | $482.1M | $2.0B |
| Q4 25 | — | 5.39× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $83.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $83.6M | ||
| Q3 25 | $-13.6M | $29.3M | ||
| Q2 25 | $-27.4M | $19.9M | ||
| Q1 25 | $-48.0M | $28.3M | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | $-58.9M | $27.8M | ||
| Q2 24 | $-53.5M | $19.7M | ||
| Q1 24 | $-62.3M | $19.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — | ||
| Q1 24 | $-62.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — | ||
| Q1 24 | -20680.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 202.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
